Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-01-01 @ 2:09 PM
Study NCT ID:
NCT01302392
Status:
COMPLETED
Last Update Posted:
2017-05-02
First Post:
2011-02-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-10
First Submit QC Date:
None
Study First Post Date:
2011-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-06
Results First Submit QC Date:
None
Results First Post Date:
2015-08-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-28
Last Update Post Date:
2017-05-02
Last Update Post Date Type:
ACTUAL